13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 39 holding rows worth $586,066,000.
- Accession
- 0000930413-18-000474
- Filer
- CIK 1281446
- Filed
- 2018-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 39 entries on the cover page, a total value of $586,066,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $586,066,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZOGENIX INC. | 98978L204 | Common Stock | 1,121,331 | $44,909,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 1,177,119 | $39,987,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,197,283 | $33,618,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 200,000 | $32,942,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 803,205 | $31,606,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 400,000 | $31,036,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 7,888,581 | $30,608,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 4,781,708 | $28,738,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 4,751,883 | $23,332,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 573,550 | $21,692,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 410,900 | $21,128,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,085,800 | $18,111,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 879,286 | $17,762,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 669,472 | $17,319,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 1,987,099 | $16,115,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 2,000,000 | $16,000,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 2,850,000 | $15,020,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 3,817,288 | $14,926,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 500,192 | $13,495,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 869,500 | $12,903,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 797,531 | $12,122,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 331,085 | $11,621,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 300,000 | $10,725,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 75,000 | $9,901,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 200,000 | $7,870,000 | thousands by filing date | call |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 313,140 | $7,703,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 173,124 | $7,347,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 70,323 | $6,660,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 800,000 | $5,440,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 200,000 | $4,290,000 | thousands by filing date | put |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 600,000 | $4,260,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,056,825 | $4,238,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 292,673 | $3,732,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 840,303 | $3,042,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 160,530 | $2,029,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 177,900 | $1,745,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 43,637 | $1,214,000 | thousands by filing date | |
| CONNECTURE INC COM | 20786J106 | Stock | 4,127,232 | $660,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 130,137 | $220,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-18-000474 | this filing | 2018-02-14 | acceptance time not in the bulk data set |